Search results
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 4 hours agoBut it can cause serious or even deadly lung infections in babies and older adults. Arexvy and...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 13 hours agoModerna's shares fell 3% to $119.02 in early trading. The Food and Drug Administration's move...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 12 hours agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...
mRNA Is Promising A Breakthrough In Fighting Cancer
Benzinga via Yahoo Finance· 2 weeks agoBy the looks of it, this was only the beginning of the healthcare revolution that mRNA triggered. Mainz Biomed...
FDA delays decision on Moderna's RSV shot until the end of May
FierceBiotech· 10 hours agoThe FDA has not raised any issues with the vaccine that could prevent approval, the company said, ...
Moderna says FDA delayed RSV vaccine approval to end of May
CNBC· 13 hours agoModerna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 12 hours agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna Says FDA Delaying Decision on RSV Vaccine Approval
Bloomberg· 12 hours agoHave a confidential tip for our reporters? US regulators’ decision on whether to approve Moderna...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 4 hours agoNovavax struggled after its COVID-19 vaccine was delayed by manufacturing issues early in...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 7 hours agoThe French drug giant Sanofi is taking a minority stake in Novavax and entering into a licensing...